198 related articles for article (PubMed ID: 33049037)
1. Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning.
Chen S; Zhang Z; Wang Y; Fang M; Zhou J; Li Y; Dai E; Feng Z; Wang H; Yang Z; Li Y; Huang X; Jia J; Li S; Huang C; Tong L; Xiao X; He Y; Duan Y; Zhu S; Gao C
J Infect Dis; 2021 Jun; 223(11):1887-1896. PubMed ID: 33049037
[TBL] [Abstract][Full Text] [Related]
2. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.
Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C
Front Immunol; 2021; 12():775461. PubMed ID: 34899733
[TBL] [Abstract][Full Text] [Related]
3. Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma.
Zhang AY; Lai CL; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
J Gastroenterol; 2017 Sep; 52(9):1064-1074. PubMed ID: 28353014
[TBL] [Abstract][Full Text] [Related]
4. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.
Bai X; Jia JA; Fang M; Chen S; Liang X; Zhu S; Zhang S; Feng J; Sun F; Gao C
PLoS Genet; 2018 Feb; 14(2):e1007206. PubMed ID: 29474353
[TBL] [Abstract][Full Text] [Related]
5. Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma.
Jia JA; Zhang S; Bai X; Fang M; Chen S; Liang X; Zhu S; Wong DK; Zhang A; Feng J; Sun F; Gao C
Virol J; 2022 Jun; 19(1):114. PubMed ID: 35765099
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing revealed divergence in deletions of the preS region in the HBV genome between different HBV-related liver diseases.
Jia J; Liang X; Chen S; Wang H; Li H; Fang M; Bai X; Wang Z; Wang M; Zhu S; Sun F; Gao C
J Gen Virol; 2017 Nov; 98(11):2748-2758. PubMed ID: 29022863
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
[TBL] [Abstract][Full Text] [Related]
8. Analysis of HBV X gene quasispecies characteristics by next-generation sequencing and cloning-based sequencing and its association with hepatocellular carcinoma progression.
Mei F; Ren J; Long L; Li J; Li K; Liu H; Tang Y; Fang X; Wu H; Xiao C; Huang T; Deng W
J Med Virol; 2019 Jun; 91(6):1087-1096. PubMed ID: 30712269
[TBL] [Abstract][Full Text] [Related]
9. Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing.
Han Y; Gong L; Sheng J; Liu F; Li XH; Chen L; Yu DM; Gong QM; Hao P; Zhang XX
Clin Microbiol Infect; 2015 Aug; 21(8):797.e1-8. PubMed ID: 25882357
[TBL] [Abstract][Full Text] [Related]
10. Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts.
Mueller-Breckenridge AJ; Garcia-Alcalde F; Wildum S; Smits SL; de Man RA; van Campenhout MJH; Brouwer WP; Niu J; Young JAT; Najera I; Zhu L; Wu D; Racek T; Hundie GB; Lin Y; Boucher CA; van de Vijver D; Haagmans BL
Sci Rep; 2019 Dec; 9(1):18892. PubMed ID: 31827222
[TBL] [Abstract][Full Text] [Related]
11. Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection.
Wang M; Chen L; Dong M; Li J; Zhu B; Yang Z; Gong Q; Han Y; Yu D; Zhang D; Zoulim F; Zhang J; Zhang X
Emerg Microbes Infect; 2021 Dec; 10(1):842-851. PubMed ID: 33870846
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatitis B virus quasispecies diversity is correlated with liver fibrosis progression.
Wu H; Liao B; Li X; Liu H; Gong M; Shi H; Xie S; Guo F; Chen K; Yan R; Zhao H; Li L; Zheng A; Liu Y; Wang Z
Infect Genet Evol; 2021 Sep; 93():104938. PubMed ID: 34029727
[TBL] [Abstract][Full Text] [Related]
13. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
14. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
Kim GA; Han S; Choi GH; Choi J; Lim YS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
[TBL] [Abstract][Full Text] [Related]
15. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis.
Wong GL; Hui VW; Tan Q; Xu J; Lee HW; Yip TC; Yang B; Tse YK; Yin C; Lyu F; Lai JC; Lui GC; Chan HL; Yuen PC; Wong VW
JHEP Rep; 2022 Mar; 4(3):100441. PubMed ID: 35198928
[TBL] [Abstract][Full Text] [Related]
16. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence.
Teng CF; Li TC; Huang HY; Lin JH; Chen WS; Shyu WC; Wu HC; Peng CY; Su IJ; Jeng LB
Viruses; 2020 Jul; 12(8):. PubMed ID: 32722114
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
20. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
J Hepatol; 2016 Jul; 65(1):48-56. PubMed ID: 27034253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
